Safety and Differential Antibody and T-Cell Responses to the Plasmodium falciparum Sporozoite Malaria Vaccine, PfSPZ Vaccine, by Age in Tanzanian Adults, Adolescents, Children, and Infants

In 2016, there were more cases and deaths caused by malaria globally than in 2015. An effective vaccine would be an ideal additional tool for reducing malaria’s impact. Sanaria(®) PfSPZ Vaccine, composed of radiation-attenuated, aseptic, purified, cryopreserved Plasmodium falciparum (Pf) sporozoites...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Trop Med Hyg
Main Authors: Jongo, Said A., Church, L. W. Preston, Mtoro, Ali T., Chakravarty, Sumana, Ruben, Adam J., Swanson, Phillip A., Kassim, Kamaka R., Mpina, Maximillian, Tumbo, Anneth-Mwasi, Milando, Florence A., Qassim, Munira, Juma, Omar A., Bakari, Bakari M., Simon, Beatus, James, Eric R., Abebe, Yonas, KC, Natasha, Saverino, Elizabeth, Gondwe, Linda, Studer, Fabian, Fink, Martina, Cosi, Glenda, El-Khorazaty, Jill, Styers, David, Seder, Robert A., Schindler, Tobias, Billingsley, Peter F., Daubenberger, Claudia, Sim, B. Kim Lee, Tanner, Marcel, Richie, Thomas L., Abdulla, Salim, Hoffman, Stephen L.
Formato: Artigo
Idioma:Inglês
Publicado em: The American Society of Tropical Medicine and Hygiene 2019
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6553883/
https://ncbi.nlm.nih.gov/pubmed/30994090
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4269/ajtmh.18-0835
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados